2Klocker N, Cellerino A, Bahr M. Related articles free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brainderived neurotrophic factor on axotomized retinal ganglion cells in vivo[J]. Neurosce, 1998,18(3)
3MansourRobaey S, Clarke DB, Wang YC, et al. Related articles effects of ocular injury and administration of brainderived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells[J]. Proc Natl Acad Sci USA, 1994,91(5): 1632-1636.
4Leith E, Barber AJ, Xu B, et al.Glial reactivity and impaired glutame metabolism in shortterm experimental diabetic retinopathy[J]. Diabetes, 1998,47(5):815-820.
5Dreyer EB, Eurakowski D, Schumer RA, et al. Elevated glutamate levels in the vitreous body of human and monkeys with glaucoma[J]. Arch Ophthalmol,1996,114(3):299-305.
6Gagliardini V, Fernandez PA, Lee RK, et al. Related articles prevention of vertebrate neuronal death by the CrmtA gene[J].Science, 1994, 263 (5148):826-828.
7Podesta F, Romeo G, Liu WH, et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivi and in vitro[J]. Am J Pathol,2000, 156(3):1025-1032.
8Hammos HP ,Federoff HT, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes[J]. Mol Med ,1995,1(5):527-534.
9Seigel GM, Chiu L, Paxhia A. Inhibition of neuroretinal cell death by insulinlike growth factor1 and its analogs[J]. Mol Vis, 2000,31(6): 157-163.
10Wang R, Ghahary A ,Shen YJ ,et al. Nitric oxide synthase expression and nitric oxide production are reduced in hypertrophic scar tissue and fibroblasts[J]. Invest Dermatol,1997,108(3): 438-444.
